PMV Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -18.7% | -18.7% | -17.4% |
| FY2022 | -29.8% | -29.8% | -27.1% |
| FY2023 | -30.6% | -30.6% | -27.3% |
| FY2024 | -33.3% | -33.3% | -30.7% |
| FY2025 | -74.2% | -74.2% | -66.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -18.7% | -18.7% | -17.4% |
| FY2022 | -29.8% | -29.8% | -27.1% |
| FY2023 | -30.6% | -30.6% | -27.3% |
| FY2024 | -33.3% | -33.3% | -30.7% |
| FY2025 | -74.2% | -74.2% | -66.7% |